Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Scleroderma, Systemic"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22%2ALung+Diseases%2C+Interstitial%22&type=Subject&filter%5B%5D=topic_facet%3A%22Scleroderma%2C+Systemic%22
/vufind/Search/Results?lookfor=%22%2ALung+Diseases%2C+Interstitial%22&type=Subject&filter%5B%5D=topic_facet%3A%22Scleroderma%2C+Systemic%22
Search /vufind/Search2/Results?lookfor=%22%2ALung+Diseases%2C+Interstitial%22&type=Subject&filter%5B%5D=topic_facet%3A%22Scleroderma%2C+Systemic%22
PubPharm (44)
1
A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients : A Phase 2 Open-Label Pilot Study of the Safety and Tolerability of Ixazomib Administered Orally to Patients With Scleroderma-Related Interstitial Lung Disease
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) : A Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-7240/PRA023 in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan : Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD) : Randomized, Double-blind, Placebo-controlled Proof-of-Concept (PoC) Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease : A Two-Cohort, Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of Vixarelimab Compared With Placebo in Patients With Idiopathic Pulmonary Fibrosis and in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Platform Clinical Study for Conquering Scleroderma : Platform Clinical Study for Conquering Scleroderma: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2b Platform Clinical Study to Evaluate the Safety and Efficacy of Investigational Products in Participants With Interstitial Lung Disease Secondary to Systemic Sclerosis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease : Multicentre Clinical Trial Evaluating the Safety and Efficacy of the Combination of Nintedanib+Tocilizumab Compared to Standard Treatment in Patients With Systemic Sclerosis and Interstitial Lung Disease. Analysis With Theranostic Approach
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease : A Two-Cohort, Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of Vixarelimab Compared With Placebo in Patients With Idiopathic Pulmonary Fibrosis and in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
"Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis" : "Effect of a Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis on Oxygen Consumption, Functionality, and Quality of Life"
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies : Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Scleroderma, Systemic
Medienart
44
Aufsätze
44
E-Artikel
44
E-Ressourcen
Zeitschriftentitel
41
ClinicalTrials.gov
1
Acta medica portuguesa
1
Revista medica del Instituto Mexicano del Segur...
1
Tuberculosis and respiratory diseases
Thema
44
Lung Diseases, Interstitial
Scleroderma, Systemic
41
610
41
Lung Diseases
40
Scleroderma, Diffuse
29
Study Type: Interventional
25
Sclerosis
15
Phase: Phase 2
13
Recruitment Status: Recruiting
12
Recruitment Status: Completed
10
Study Type: Observational
7
Phase: Phase 3
7
Scleroderma, Localized
6
Pulmonary Fibrosis
5
Recruitment Status: Terminated
5
Recruitment Status: Unknown status
4
Connective Tissue Diseases
4
Idiopathic Pulmonary Fibrosis
4
Recruitment Status: Not yet recruiting
3
Arthritis
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
29
2020-
15
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
43
Englisch
1
Spanisch
Haven't found what you're looking for?
Wird geladen...